1.
Trends Pharmacol Sci
; 45(4): 283-286, 2024 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38355323
RESUMEN
Navigating the ever-evolving landscape of nuclear magnetic resonance (NMR) poses challenges for the industry. This work explores promising approaches that illuminate protein-ligand interactions in the context of structural dynamics, facilitating targeted drug discovery. I acknowledge existing limitations and highlight future opportunities, which may pave the way for broader NMR integration and faster therapeutic development.